MilliporeSigma, the Life Science business of Merck KGaA in the U.S. and Canada, has announced a definitive agreement to acquire HUB Organoids Holding B.V. (HUB). This acquisition marks a significant step forward in enhancing their 2D and 3D cell culture portfolio with the innovative technology of
In the ever-evolving field of biotechnology, cell and gene therapy offer unprecedented potential to treat diseases once considered untreatable. However, recent evidence suggests that the conventional methods of culturing cells might be hindering progress. Researchers are now reconsidering the
The Europe Plant Cell Culture Equipment Market is poised for significant growth from 2024 to 2031. This article delves into the various facets of this burgeoning market, providing a comprehensive analysis that includes market dynamics, product segmentation, regional insights, competitive landscape,
The "3D Cell Culture Market" is a pivotal segment within biotechnology, focusing on creating and using three-dimensional environments for cell culture. Unlike traditional two-dimensional cultures, this method more accurately mimics the natural tissue context, providing more relevant physiological
The Mesenchymal Stem Cells (MSC) market is experiencing rapid growth, driven by an aging global population, advancements in regenerative medicine, and technological innovations in biotechnology. Valued at USD 3.2 billion in 2023, the market is anticipated to reach USD 9.72 billion by 2032, with a
Neutrophils, a type of white blood cell, are essential players in the immune system, responsible for responding to infections and inflammation. Their ability to migrate to sites of infection is crucial for effective immune responses. However, the behavior of neutrophils can be influenced by various
